Study: Accuracy of Five Self‐Report Screening Instruments for Substance Use in Pregnancy
Nearly one-fourth of pregnant women report having used alcohol, tobacco, or other substances in the past month, yet current screening questionnaires used by physicians may not accurately identify many of them. Kimberly A. Yonkers, MD, Professor of Psychiatry, of Epidemiology (Chronic Diseases) and of Obstetrics, Gynecology, and Reproductive Services at Yale School of Medicine, was the senior researcher among investigators across three universities who compared results of five commonly used questionnaires against laboratory testing.
Yonkers, Forray Co-PIs on New Grant to Study Medication Delivery for Pregnant Women with Opioid Use Disorders
Kimberly Yonkers, MD, Professor of Psychiatry, of Epidemiology (Chronic Diseases) and of Obstetrics, Gynecology, and Reproductive Services, and Ariadna Forray, MD, Associate Professor of Psychiatry, are co-principal investigators on a new $5.5 million grant to study models to improve delivery of office-based medication treatment for pregnant women with opioid use disorder in prenatal clinics.
Don't Jump for Joy over New FDA-approved Postpartum Depression Medicine Yet
Kimberly Yonkers, MD, Professor of Psychiatry, of Epidemiology (Chronic Diseases) and of Obstetrics, Gynecology, and Reproductive Sciences cautions new mothers who may consider taking the new FDA-approved medication for postpartum depression in an opinion piece published in USA Today.
Yonkers recruited to head Psychological Medicine at Yale New Haven Hospital
Kimberly A. Yonkers, MD, Professor of Psychiatry, Epidemiology (Chronic Disease), and Gynecology and Reproductive Sciences and Director of the Center for Wellbeing of Women and Mothers at Yale School of Medicine, has been recruited to lead the Section of Psychological Medicine within the Department of Psychiatry and Behavioral Health of Yale New Haven Hospital.
Yonkers honored with Harold R. Behrman Mentoring Award
Kimberly A. Yonkers, MD, Professor of Psychiatry, of Epidemiology (Chronic Diseases) and of Obstetrics, Gynecology, and Reproductive Services, has been awarded the Harold R. Behrman Mentoring Award from the Yale Department of Obstetrics, Gynecology and Reproductive Services.
Many Women in Low-Income Areas Have Poor Access to Obstetric and Neonatal Care, Study Finds
A research team led by the Yale School of Public Health has found that many pregnant women in low-income areas have to travel farther than their peers to reach the nearest hospitals to deliver their babies-and the gap in accessible health care appears to be growing.
Mother's psychiatric diagnosis no threat to baby's health
Depression, panic disorder, and generalized anxiety disorder represent no threat to the health of pregnant women or their babies, although there may be slight risks associated with medications used to treat those conditions, according to a new Yale study. Lead author Kimberly Yonkers, MD, is Professor of Psychiatry, Epidemiology, and Obstetrics, Gynecology, and Reproductive Services, as well as Director of the Center for Wellbeing of Women and Mothers.
More than half of rural counties don’t have a hospital where women can give birth
At Meadows Regional Medical Center in rural Vidalia, Ga., the number of babies born each year has more than doubled over the last 15 years — increasing from about 400 births in 2000 to more than 800 in recent years, according to the hospital's chief executive Alan Kent.
$1.8 Million Granted to Yale School of Public Health to Study Effectiveness of HPV Vaccine
A $1.8 million National Institutes of Health grant will help researchers at the Yale School of Public Health shed light on the real-world effectiveness of the Human Papillomavirus (HPV) vaccine. Results of this study can ultimately help to maximize the vaccine’s impact on several types of cancer.
Acupuncture, Widely Used, Found to be Ineffective in Improving Live Birth Rate
In a surprising finding, a collaboration between the researchers in China, the United States and Europe reveals that acupuncture is ineffective in improving live birth rate in women with Polycystic Ovarian Syndrome, or PCOS, contrary to prevailing wisdom and common practice.
Women’s Health Research at Yale funds studies on colon cancer, infections in pregnancy, and domestic violence
“Through our competitive peer review process, these three studies stood out as extremely promising opportunities to improve and even save lives,” said Dr. Carolyn M. Mazure, director of WHRY. “With these new grants, we continue to expand a broad scope of existing work to focus on questions vital to the health and well-being of millions of women, men, and children.”
Low level drinking in pregnancy not associated with higher risk of poor birth outcomes
Heavy alcohol consumption during pregnancy has long been linked to a range of developmental problems and birth defects including fetal alcohol syndrome (FAS), low birth weight, and preterm delivery, but a new study from Yale and Brown University shows that low to moderate alcohol consumption is not associated with an increased risk of specific birth outcomes and measures of fetal growth.
Multiple births don’t have to be an inevitable result of fertility treatments
While fertility treatments have helped many people become parents, they commonly result in multiple births, increasing the risk of prematurity, and leading to lifelong complications. But this doesn’t have to be the case, according to Yale School of Medicine researchers and their colleagues, who recommend sweeping changes to policy and clinical practice in a study published in the April issue of Fertility & Sterility.
Yale partners with Ghana to eliminate mother-to-child HIV transmission
Yale University is collaborating with the government of Ghana and other high-profile organizations to eliminate mother-to-child transmission of HIV in Ghana. President John Dramani Mahama has announced the formation of a global consortium that also includes IBM, The ONE Campaign to prevent poverty and disease, and several local partners in Ghana.
For women with hysterectomies, estrogen may be a lifesaver after all
The widespread rejection of estrogen therapy after the 2002 Women’s Health Initiative (WHI) study has most likely led to almost 50,000 unnecessary deaths over the last 10 years among women aged 50 to 69 who have had a hysterectomy, Yale School of Medicine researchers reveal in a study published in the July 18 issue of the American Journal of Public Health.